Ongoing research in the field ofprevention and effective treatment of kidney stone diseases is expected toimpact the KidneyStone Management Devices Market. For instance, in 2017, Duke ClinicalResearch Institute (DCRI), scientific data research center for the UrinaryStone Disease Research Network, launched a two year clinical trial to determinethe ways to prevent recurrence of kidney stones. Moreover, in 2016, AmericanUrological Association (AUA) released new guidelines for surgical treatment ofpatients with renal stones. The most pertinent change was decision abouttreatment and therapy for kidney stones, which should be shared betweenphysician and patients. These guidelines state expert recommendations inrelation to treatment of renal stones, small hard mineral deposits inside thekidneys and ureteral stones.
Urolithiasis is the most frequentand common urological disease, which involves stone formation in the kidney,bladder, and urinary tract. The reasons behind stone development in abovementioned areas are mainly associated with decreased urine volume and increasedexcretion of stone-forming substances such as oxalate, calcium, cysteine,urate, phosphate, and xanthine. Kidney stones can be treated effectively, due topresence of advanced methods and associated medical devices. According to theAmerican Urologic Association (AUA), direct and associated treatment costrelated to kidney stone diagnosis and management has increased over the pastfew years. Despite recent advancements in therapeutic and surgical treatmenttechniques, the overall health care expenditure for the kidney stone diseasemanagement has increased. According to National Center for BiotechnologyInformation (NCBI), the cost for medical management of kidney stones isexpected to reach to US$ 1.24 Bn annually in the U.S. by 2030. Cost containmentfor the patients has been made possible by technological development in termsof shorter duration hospital stays and more minimally invasive surgicalprocedures.
* The sample copy includes: Report Summary, Table ofContents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/1030
Kidney stones can occur in one orboth kidneys. It can affect people between ages of 30 to 60 years according tothe National Health Service (NHS). Furthermore, the global prevalence of kidneystones annually is three in 20 men and two in 20 women according to NHS. TheU.S. National Health and Nutrition Examination Survey (NHANES), published in2012, stated that the prevalence of kidney stones in men was 10.6% and was 7.1%in women.
New product launches and ongoingresearch on prevention and treatment of kidney stones is expected to boost themarket growth over the forecast period
Technological advancements andinnovative product launches have allowed for therapy optimization and bettermanagement of the stones irrespective of their sizes. Terumo Corporationlaunched GLIDEWAY ureteral access sheath, which was used in minimally invasiveurologic procedures in 2014. Boston Scientific launched LithoVue single usedigital flexible ureteroscopes in Europe in 2016, which provided high-qualityvisualization better than leading ureteroscopes at the time.
Technological advancement in thesurgical procedures requiring minimal invasion is expected to boost the growthof the kidney stone management devices market
Advancements in the surgicalprocedures to treat kidney stones such as Extracorporeal Shock Wave Lithotripsy(ESWL), Ureteroscopy, and Percutaneous Nephrolithotomy have simplified thesurgical procedures over the years. Advent of high resolution imaging devices,increased availability of flexible ureteroscopes and lithotripsy devices, anddecreased invasiveness of the procedures have helped to favorably shape thekidney stone management devices market.
Browse ResearchReport: https://www.coherentmarketinsights.com/ongoing-insight/kidney-stone-management-devices-market-1030
Smaller and more flexibleureteroscopes namely LithoVue and effective stone retrieval devices have beenmade available by the industry players to increase the efficacy of the surgicalprocedures. These cost-effective techniques have allowed faster recovery withfew treatment cycles requiring minimal sedation. Ureteroscopy is beingpreferred more currently, owing to advantages, such as immediate stone removaland low risk of complications, especially in treatment of symptomatic stoneslocated in pelvic kidneys, where this technique excels over the other two.Increasing reimbursement support from government and private sources formedical devices such as separate reimbursements for physician payment, hospitaloutpatient, and hospital inpatient by Medicare as well as implementation of theAffordable Care Act (ACA) in the U.S. has been a major growth factor for thekidney stone management devices market.
Key players in the kidney stonemanagement devices market
Some of the key players operatingin the kidney stone management devices market include Bard Medical Division,Coloplast Group, Allengers Medical Systems, Boston Scientific Corporation, CookMedical, Electro Medical Systems, Lumenis Ltd., Storz Medical AG, DornierMedtech, and Richard Wolf GmbH.
Buy-Now this researchreport: https://www.coherentmarketinsights.com/insight/buy-now/1030
AboutCoherent Market Insights:
CoherentMarket Insights is a prominent market research and consulting firm offeringaction-ready syndicated research reports, custom market analysis, consultingservices, and competitive analysis through various recommendations related toemerging market trends, technologies, and potential absolute dollaropportunity.
ContactUs:
mailto:sales@coherentmarketinsights.com
U.S.Office:
Name: Mr. Shah
CoherentMarket Insights 1001 4th Ave,
# 3200Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN: +050-5539-1737
